ad image

Opioid Withdrawal

1 / 1
Braeburn
Opioid Disorder

Braeburn Submits Request for Final Approval of BRIXADI for the Treatment of Opioid Use Disorder

Braeburn

PR-M06-20-NI-014Jun 11, 2020
New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA
FDA Approval

New Treatment for Management of Opioid Withdrawal Symptoms Approved by FDA

Emilie Branch

Pharma's Almanac

PAO-M05-18-NI-019May 24, 2018
U.S. Food & Drug Administration
FDA Approval

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

U.S. Food & Drug Administration

PR-M05-18-NI-079May 21, 2018
1 / 1